HIPK2对HIF-1α转录活性及泛素化的调控在低氧诱导视网膜新生血管中的作用
批准号:
82101133
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
杨博宇
依托单位:
学科分类:
视网膜、脉络膜及玻璃体相关疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
杨博宇
中文摘要
视网膜新生血管(RNV)的发生与低氧状态下HIF-1α稳定性增加密切相关。HIPK2是HIF-1α关键上游抑制分子,被认为是极具潜力的抗肿瘤治疗靶点,但在RNV中的作用尚不清楚。我们发现:HIPK2在OIR小鼠视网膜中低表达,其过表达显著抑制HIF-1α转录并促进其泛素化,抑制VEGF和RMECs细胞迁移及成管。研究报道HIF-1α也可以负调控HIPK2。故提出假说:HIPK2通过调控HIF-1α转录活性及泛素化影响RNV发生,且二者存在相互抑制的反馈回路。本课题拟在体外低氧模型中探讨HIPK2对HIF-1α转录活性和泛素化的调控作用,明确HIPK2结合HIF-1α的启动子位点以及HIPK2-HIF-1α相互抑制作用;并通过体内外靶向干预HIPK2表达,明确对HIF-1α/VEGF通路、RMECs生物学特性及RNV发生的影响。本研究将为RNV发病机制及靶向药物的开发提供新的理论和实验依据。
英文摘要
Retinal neovascularization (RNV) is a common and refractory eye disease that causes vision loss. HIF-1α accumulation caused by hypoxia is believed to play an important role in the pathological process of RNV. HIPK2 is an important upstream negative regulator of HIF-1α expression, which has been considered as a promising biomarker and a target for tumor therapy. However, the underlying role of HIPK2 in RNV development remains unclear. Our preliminary results suggested that hypoxia down-regulated the mRNA and protein expression of HIPK2 in retina from oxygen-induced retinopathy model and in vitro hypoxia-stimulated retinal microvascular endothelial cells (RMECs). Overexpression of HIPK2 significantly inhibited the transcriptional activity and promoted the ubiquitination of HIF-1α, decreased VEGF secretion and inhibited RMECs migration and lumen formation. On the contrary, it was reported that HIF-1α could negative regulate HIPK2 expression. Based on this, we put forward the hypothesis that HIPK2 affects the occurrence and development of RNV by regulating the transcriptional activity and ubiquitination of HIF-1α. Besides, there exist a negative feedback loop between HIF-1α and HIPK2. In this study, dual-luciferase reporter assay, co-immunoprecipitation and ubiquitination detection are used to investigate the regulation role of HIPK2 on the transcriptional activity and ubiquitination of HIF-1α in hypoxia-stimulated RMECs, then identify the HIF-1α promoter region repressed by HIPK2 and analyze the mutual negative regulation role between HIF-1α and HIPK2. Furthermore, HIPK2 knockout or overexpression RMECs induced by lentivirus and HIPK2 conditional knockout transgenic mice are used to determine the effects of HIPK2 on the HIF-1α/VEGF signaling pathway, RMECs proliferation, apoptosis, migration, lumen formation, inflammatory cytokines production and RNV development. This study is expected to provide new pathogenesis and therapeutic target for RNV, which has an important theoretical and experimental significance.
视网膜新生血管(RNV)是目前常见且难治的致盲性眼病,RNV的发生与低氧状态下低氧诱导因子-1α(HIF-1α)稳定性增加密切相关,同源结构域相互作用蛋白激酶2(HIPK2)是HIF-1α关键上游抑制分子,但在RNV中的作用尚不清楚。本研究以氧诱导视网膜病变(OIR)小鼠模型及体外低氧诱导的细胞模型为研究对象,通过敲除和过表达HIPK2,深入探究了HIPK2通过调控HIF-1α转录活性和泛素化修饰对RNV生成的影响。进一步从HIPK2下游通路入手,聚焦HIF-1α新型小分子抑制剂IDF-11774,探讨其对RNV治疗的疗效和安全性。研究发现在OIR模型中,HIPK2敲除显著加重OIR小鼠视网膜新生血管区和无血管区面积、增加视网膜血管内皮细胞的增殖活性及通透性、促进炎症细胞募集、胶质化增生和神经节细胞丢失。在体外实验中,过表达HIPK2通过抑制HIF-1α的转录活性并促进其泛素化降解,抑制HIF-1α和VEGF的表达及低氧诱导的视网膜微血管内皮细胞迁移及管腔形成。在HIF-1α抑制剂IDF-11774治疗RNV方面,IDF-11774通过泛素-蛋白酶体途径促进缺氧诱导的血管内皮细胞中HIF-1α降解,抑制OIR模型RNV形成、促进生理性血管重建,改善视网膜高通透性、维持血视网膜屏障的完整性、增强周细胞覆盖并维持内皮粘附连接。通过Bulk RNA-seq分析和细胞实验验证,IDF-11774可以维持OIR视网膜中促血管生成因子和抑血管生成因子的平衡,抑制缺氧诱导的内皮细胞中血管调节因子如ANGPT2和PlGF的上调。此外,玻璃体腔注射IDF-11774对视功能及视网膜组织结构均无不良影响。本研究为视网膜新生血管性疾病的发病机制、靶向药物的开发和临床转化提供了重要的理论和实验依据。
慢性眼移植物抗宿主病结膜血管增生的动态观察及其机制研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:杨博宇
-
依托单位:
国内基金
海外基金